Navigation Links
SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
Date:10/26/2007

TSX symbol: SBS

CALGARY, Oct. 26 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it will be presenting a scientific poster and abstract at the Seventh Annual Diabetes Technology Meeting in San Francisco hosted by the Diabetes Technology Society. The poster will disclose SemBioSys' recent accomplishments in the development of a highly-scalable, low-cost source of recombinant human insulin. Poster session presentations will take place at the San Francisco Airport Hyatt Regency Hotel on Friday, October 26 from 6:00pm to 8:00pm. The poster and abstract are titled:

"Chemical and Biological Characterization of Recombinant Human Insulin Produced in Transgenic Plants," by Joseph Boothe, Cory Nykiforuk, Elizabeth Murray, Philip Kuhlman, W. Brent Pollock, Amanda Bodero, Joseph Goren, Richard Keon, Steven Szarka, Nancy Markley, and Maurice Moloney.

About SemBioSys Genetics Inc. (http://www.sembiosys.com)

Calgary, Alberta-based SemBioSys Genetics Inc. is a biotechnology company developing protein-based pharmaceuticals for metabolic and cardiovascular diseases. The Company's lead pharmaceutical candidates, produced in the plant host safflower, are recombinant human insulin to serve the rapidly expanding global diabetes market and Apo AI, a next generation cardiovascular drug. In addition to its pharmaceutical products SemBioSys is developing a series of non-pharmaceutical products addressing human topical, nutritional oils and animal health markets.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and other similar expressions which constitute "forward-l
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...EN, Nov. 19 Danish Prince Joachim ... ethanol plant in Kalundborg, Denmark, on Wednesda... first and largest 2nd generation ethanol demonstr...s are used in the plant,s innovative process for c...anisco, was the first to market with commercial en...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha...he previously reported $6.3 million registered dir...870 shares of its common stock and warrants to pur...
(Date:11/19/2009)...VERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswire/... Resources find that the leading driver of antibio... broad-spectrum activity against gram-positive and...ganisms that can cause nosocomial pneumonia, surve...arily for agents that provide appropriate coverage...
(Date:11/19/2009)... Top LASIK surgeons and recognized refracti...LASIK Surgeons made brought their fellow surgeons ...rrection surgery, cataract surgery, and ophthalmol...Academy of Ophthalmology (AAO) annual meeting in S...r. Shachar Tauber, Dr. David Huang, MD, Dr. Randy ...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
...eb. 5 CryoLife, Inc. (NYSE: CRY ), a biomateria...announced today that 2008 fourth quarter and year ..., February 19, 2009. The Company will hold a tele...tern Time, February 19, 2009, to discuss the resul...ed by Steven G. Anderson, president and CEO of Cry...
...Md., Feb. 5 Micromet, Inc. (Nasdaq: MITI ), tod...tian Itin, will present at the BIO CEO and Investo...ty on Tuesday, February 10, 2009. A simultaneous w...e company,s website at www.micromet-inc.com . , ...: Tuesday, February 10, 2009, Time: 2:1...
... N.J., Feb. 5 Sopherion Therapeutics, LLC, a biop...nd commercialization of anti-cancer therapies, tod...I/II study of nonpegylated liposomal doxorubicin (...cer Research . The study was supported by a grant...t Cancer Cooperative Group (SOLTI). , , The study...
Other Biology Technology:CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 3Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 4Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 2Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 3Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients 4
(Date:11/20/2009)...T researchers are at work on many scientific and t...ation has recently provided support that totals ne...ollowing investigators under the American Recovery...ers have been awarded grants for investigation of ...ofessor of physics, will enhance the capabilities ...
(Date:11/20/2009)...RBOR, Mich.---We,ve all read studies about the hea...ing is true at the molecular level, where amino ac... damage when single than when paired up with other... of Michigan, along with colleagues in Belgium, ha...ts single cysteines. The research appears in the N...
(Date:11/20/2009)...ade ago, a group of University of Oklahoma researc... part of the human genome project. Today, the OU...ting to an international effort to sequence the to...he National Science Foundation for plant genomics....tance, so improving the tomato and crop yields wil...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Saving the single cysteine: New antioxidant system found 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 9223 1M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 9223 2Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market Finds Frost 26 Sullivan 9221 1Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market Finds Frost 26 Sullivan 9221 2Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market Finds Frost 26 Sullivan 9221 3New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 1New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 2New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 3New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 4New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 5New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 6New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 7New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 8New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 9New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 10New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 11New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 12New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 13New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 14New Report Just Published 3A World Solid State Fiber Gas and Dye Lasers Market Report 9219 15
...monstrated that a gel applied in the vagina provid... virus (HIV) and the herpes simplex Virus. The stu...es and Opportunistic Infections, is the first to s...in the human vagina. , The study, which was funde...tigated the efficacy of PRO 2000, a topical microb...
... causes dysentery uses a ,sword and shield, approa...blished today in Science, the team from Imperial C...hat shigella, the bacteria which causes dysentery,...nse from the immune system. , They found that shi...n system to inject proteins into human cells, (the...
...s from the United States, Sweden and Japan has dis...s sufficient to change the normal balance of cells...the risk that a cancer-causing genetic mutation wi...ople have this double protein dose as well. , In ...hers report that mice engineered to have a double ...
Other Biology News:Topical treatment shown to inhibit HIV and herpes simplex virus infection 2It's not all genetic: Common epigenetic problem doubles cancer risk in mice 2It's not all genetic: Common epigenetic problem doubles cancer risk in mice 3
DUALmembrane starter package from Dualsystems Biotech AG
Rabbit Anti-p38 alpha Polyclonal Antibody, Unconjugated from R&D Systems
Human Serum Type AB from Irvine Scientific
Anti-alpha1-Antitrypsin Monoclonal Antibody, Unconjugated from CHEMICON
Biology Products: